Suppression of facilitative glucose transporter 1 mRNA can suppress tumor growth.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cancer Letters

• Publication date

  2000-06-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0304-3835(00)00392-XPMID 10806305
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of glucose transporter gene expression by antisense nucleic acids in HL-60 leukemia cells.

  1999cited by this paper
• Glucose uptake in the human gastric cancer cell line, MKN28, is increased by insulin stimulation.

  1999cited by this paper
• GLUT1 glucose transporter expression in colorectal carcinoma

  1998cited by this paper
• Effects of noradrenaline on the cell-surface glucose transporters in cultured brown adipocytes: novel mechanism for selective activation of GLUT1 glucose transporters.

  1998cited by this paper
• Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage.

  1998cited by this paper
• Efficient Transport and Accumulation of Vitamin C in HL-60 Cells Depleted of Glutathione*

  1997cited by this paper
• Overexpression of glut1 and glut3 in stage I nonsmall cell lung carcinoma is Associated with poor survival

  1997cited by this paper
• Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.

  1997cited by this paper
• Glucose‐transporter‐type‐I‐gene amplification correlates with Sialyl‐Lewis‐X synthesis and proliferation in lung cancer

  1997cited by this paper
• Expression of the GLUT1 glucose transporter increases thymidine uptake in Chinese hamster ovary cells at low glucose concentrations.

  1991cited by this paper
• Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis.

  1990cited by this paper
• Over-expression of facilitative glucose transporter genes in human cancer.

  1990cited by this paper
• Elevation of facilitated glucose‐transporter messenger RNA in human hepatocellular carcinoma

  1990cited by this paper
• Regulation of Glucose-Transporter Gene Expression In Vitro and In Vivo

  1990cited by this paper
• Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes.

  1987cited by this paper
• The glucose transporter of mammalian cells.

  1985cited by this paper
• Transport of sugars in tumor cell membranes.

  1974cited by this paper
• The effects of reciprocal changes in temperature on the transformed state of cells infected with a rous sarcoma virus mutant.

  1971cited by this paper

• The Expression and Prognostic Value of Multiple Glucose Transporters in Cutaneous Melanoma

  2024cites this paper
• Nanotandem-rocket releases messenger to disrupt metabolic communication for antitumor immunotherapy

  2023cites this paper
• Single-Cell Multi-Modal GAN (scMMGAN) reveals spatial patterns in single-cell data from triple negative breast cancer

  2022cites this paper
• Single-cell multi-modal GAN reveals spatial patterns in single-cell data from triple-negative breast cancer

  2022cites this paper
• Obesity and Energy Substrate Transporters in Ovarian Cancer—Review

  2021cites this paper
• Interval Exercise Training Affects Expression of MCT-1, GLUT-1, PFK-1 and p53 as Key Metabolic Regulators on Azoxymethane-Induced Experimental Colon Cancer

  2021cites this paper
• Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential.

  2020cites this paper
• Glucose transporter 1 in health and disease

  2019cites this paper
• Maspin and GLUT-1 expression in endometrial carcinomas and prognostic relevance

  2019cites this paper
• GLUT 1 expression is a supportive mean in predicting prognosis and survival estimates of endometrial carcinoma.

  2019cites this paper
• Morin and Esculetin supplementation modulates c‐myc induced energy metabolism and attenuates neoplastic changes in rats challenged with the procarcinogen 1,2 ‐ dimethylhydrazine

  2017cites this paper
• The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis

  2017cites this paper
• Differential relationship between two hypoxia markers: HIF-1α and GLUT1 and classic prognostic factors in invasive breast carcinoma

  2016cites this paper
• Targeting Warburg Effect in Cancers with PEGylated Glucose

  2016cites this paper
• Zróżnicowana zależność pomiędzy dwoma markerami hipoksji: HIF-1α i GLUT1 aklasycznymi czynnikami prognostycznymi w inwazyjnym raku piersi

  2016cites this paper
• The effects of hyperglycemia on glucose metabolism in epithelial ovarian cancer

  2016cites this paper
• Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response.

  2016cites this paper
• Roles of glucose transporter-1 and the phosphatidylinositol 3‑kinase/protein kinase B pathway in cancer radioresistance (review).

  2015cites this paper
• Deregulated SLC2A1 Promotes Tumor Cell Proliferation and Metastasis in Gastric Cancer

  2015cites this paper
• Self-Targeting Fluorescent Carbon Dots for Diagnosis of Brain Cancer Cells.

  2015cites this paper
• L-Methionase: A Therapeutic Enzyme to Treat Malignancies

  2014cites this paper
• Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery

  2014cites this paper
• Role of stromal fibroblasts in prostate carcinoma progression and metabolic reprogramming of cancer cells

  2014cites this paper
• The Role of Hypoxia-Inducible Factor-1α, Glucose Transporter-1, (GLUT-1) and Carbon Anhydrase IX in Endometrial Cancer Patients

  2014cites this paper
• Galactodendritic Phthalocyanine Targets Carbohydrate-Binding Proteins Enhancing Photodynamic Therapy

  2014cites this paper
• EXPRESSION AND SIGNIFICANCE OF PTEN AND GLUT-1 IN PROLIFERATIVE ENDOMETRIUM, ENDOMETRIAL HYPERPLASIA AND ENDOMETRIOID ADENOCARCINOMA.

  2014cites this paper
• Effect of Antisense Oligodeoxynucleotides Glucose Transporter-1 on Enhancement of Radiosensitivity of Laryngeal Carcinoma

  2013cites this paper
• ¹⁸F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma.

  2012cites this paper
• Expression and clinical significance of glucose transporter 1 mRNA in bronchial brushing liquid‐based cytology specimens from patients with and without lung cancer

  2012cites this paper
• [The role of glucose transporter 1 (GLUT1) in the diagnosis and therapy of tumors].

  2012cites this paper
• Recent advances in brain tumor-targeted nano-drug delivery systems

  2012cites this paper
• Modelling non-homogeneous stochastic reaction-diffusion systems: the case study of gemcitabine-treated non-small cell lung cancer growth

  2012cites this paper
• ESTUDO DA IMUNOEXPRESSÃO DOS TRANSPORTADORES DE GLICOSE 1 E 3 EM CARCINOMAS EPIDERMÓIDES DE LÁBIO INFERIOR E SUA RELAÇÃO COM PARÂMETROS CLÍNICO-PATOLÓGICOS

  2012cites this paper
• Metabolite channeling and compartmentation in the human cell line AGE1.HN determined by 13C labeling experiments and 13C metabolic flux analysis.

  2011cites this paper
• Modulation of Glucose Transporter 1 (GLUT1) Expression Levels Alters Mouse Mammary Tumor Cell Growth In Vitro and In Vivo

  2011cites this paper
• Effects of suppressing glucose transporter-1 by an antisense oligodeoxynucleotide on the growth of human hepatocellular carcinoma cells.

  2011cites this paper
• Expression of GLUT-1 in epithelial ovarian carcinoma: correlation with tumor cell proliferation, angiogenesis, survival and ability to predict optimal cytoreduction.

  2011cites this paper
• Aerobic glycolysis: meeting the metabolic requirements of cell proliferation.

  2011cites this paper
• Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.

  2010cites this paper
• Akt inhibitors reduce glucose uptake independently of their effects on Akt.

  2010cites this paper
• Glucose Transporter-1 as a New Therapeutic Target in Laryngeal Carcinoma

  2010cites this paper
• Advances in research of primary gallbladder carcinoma at the genetic level

  2009cites this paper
• GLUT1 as a therapeutic target in hepatocellular carcinoma

  2009cites this paper
• Inhibition of cell proliferation and glucose uptake in human laryngeal carcinoma cells by antisense oligonucleotides against glucose transporter‐1

  2009cites this paper
• Tumor cell energy metabolism and its common features with yeast metabolism.

  2009cites this paper
• GLUT1 gene is a potential hypoxic marker in colorectal cancer patients

  2009cites this paper
• Glucose transporter-1 expression and prognostic significance in pancreatic carcinogenesis.

  2009cites this paper
• Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability.

  2008cites this paper
• Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1α/GLUT-1 expression

  2008cites this paper
• Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies

  2008cites this paper
• Expression of hypoxia inducible factor-1alpha (HIF-1alpha) and glucose transporter-1 (GLUT-1) in ovarian adenocarcinomas: difference in hypoxic status depending on histological character.

  2008cites this paper
• Award Number: W81XWH-07-1-0348 TITLE: Development of Anti-GLUT-1 Antibody as a Novel Therapeutic Strategy against Breast Cancer

  2008cites this paper
• Glut-1 antibodies induce growth arrest and apoptosis in human cancer cell lines.

  2007cites this paper
• Expression of GLUT1 in primary renal tumors: morphologic and biologic implications.

  2007cites this paper
• An Up-to-Date Anti-Cancer Treatment Strategy Focusing on HIF-1α Suppression: Its Application for Refractory Ovarian Cancer

  2007cites this paper
• Engineering cells for cell culture bioprocessing--physiological fundamentals.

  2006cites this paper
• Fedbatch culture and dynamic nutrient feeding.

  2006cites this paper
• GLUT-1 is Preferentially Expressed in Atypical Endometrial Hyperplasia and Endometrial Adenocarcinoma

  2006cites this paper
• Identification of a novel SEREX antigen, SLC2A1/GLUT1, in esophageal squamous cell carcinoma.

  2006cites this paper
• Regulation of human peptide transporter 1 (PEPT1) in gastric cancer cells by anticancer drugs.

  2005cites this paper
• Adenoviral modulation of the tumor‐associated system L amino acid transporter, LAT1, alters amino acid transport, cell growth and 4F2/CD98 expressionwith cell‐type specific effects in cultured hepatic cells

  2005cites this paper
• Glucosylated polyethylenimine as a tumor-targeting gene carrier

  2005cites this paper
• Glucose transporter GLUT1 in colorectal adenocarcinoma cell lines is inversely correlated with tumour cell proliferation.

  2005cites this paper
• Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer

  2005influential citation
• Diagnostic Utility of GLUT-1 Expression in the Cytologic Evaluation of Serous Fluids

  2005cites this paper
• The Akt pathway: molecular targets for anti-cancer drug development.

  2004cites this paper
• Oncogenes modulate cell sensitivity to apoptosis induced by glucose deprivation.

  2004cites this paper
• Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection; results of EORTC Translational Research Fund studies.

  2004cites this paper
• Expression of glucose transporter 1 (Glut-1) in cell lines and clinical specimens from human prostate adenocarcinoma.

  2004cites this paper
• 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.

  2004cites this paper
• Inhibition of cell proliferation in human breast tumor cells by antisense oligonucleotides against facilitative glucose transporter 5

  2004cites this paper
• Akt-Directed Glucose Metabolism Can Prevent Bax Conformation Change and Promote Growth Factor-Independent Survival

  2003cites this paper
• Variability in glucose transporter-1 levels and hexokinase activity in human melanoma

  2002cites this paper
• Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.

  2002cites this paper
• High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers.

  2002cites this paper
• GLUT‐1 expression in ovarian carcinoma

  2001cites this paper
• Renal Carcinomas in Clear Cell α Overexpression of Hypoxia-inducible Factor-1 Constitutive Activation of Hypoxia-inducible Genes Related to Updated Version

  2001cites this paper
• Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.

  2001cites this paper
• Current gene therapy for stomach carcinoma.

  2001cites this paper